These latest guidelines are one of the key deliverables in the EU action plan on AMR.
They provide, at a glance, Member States authorities, farmers and veterinarians with practical examples of what is being done in other EU countries to promote the prudent use of antimicrobials in veterinary medicine. Such measures can contribute to the control of AMR also in human medicine. Antimicrobials are essential in combatting infectious diseases and AMR is a serious threat both for human and animal health.
Since AMR can be transferred from animals to humans and vice-versa via direct and indirect contact, a "One Health" approach based on collaboration and joined-up thinking of both human and veterinary medicine sectors is essential to tackle this issue at EU and global level. AMR remains a priority for the EU which published in November 2011 a five-year Action Plan designed to address the growing risks posed by AMR. A progress report on the 12 actions outlined in the plan was published earlier this year.
AMR develops when microorganisms no longer respond to drugs they were previously sensitive to. Regular reports by the Commission’s agencies, EMA, EFSA and ECDC can be found under latest updates.
